Kurs
-0,53%
Kurs
-0,53%
Open
37,60
High
38,85
Low
36,70
Close
37,40
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
0,55 MNOK
Likviditet
0,55 MNOK
Rel. mcap
0,01%
Antal aktier
14 574
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-10-31 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-11 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-28 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2025-04-25 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-09 | - | X-dag ordinarie utdelning AKBM 45.00 NOK |
| 2024-09-03 | - | Extra Bolagsstämma 2024 |
| 2024-07-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-17 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2024-04-16 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-01 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-01 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-14 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-14 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-15 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2021-03-12 | - | Årsstämma |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-15 | - | Kvartalsrapport 2020-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2023-05-04 12:10:46
4 May 2023: Reference is made to the stock exchange announcement on 26 April
2023 by Aker BioMarine ASA regarding the expected approval of Superba krill oil
in South Korea. Aker BioMarine and its long-term local partner have today
received the final approval from the Korean Ministry of Food and Drug Safety for
Superba krill oil as Health Functional Food in South Korea.
For further information, please contact
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.Klaveness@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.